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Abstract
This study sought to explore the consistency of patient recall compared with data found in health care records
in the setting of referral to a gynecologic oncologist for suspected ovarian cancer. Ninety-one patients were
interviewed regarding symptoms and health care events, and the dates leading to diagnosis and medical
record histories were obtained and abstracted. There was low correspondence between patient recall and the
medical record for time to diagnosis and health care events. This study emphasizes the need to find a way to
obtain information about patient history and test results directly from providers in a timely manner, as patients
often do not even recall the health care events or tests they have received.
Introduction: Patient recall is often used by clinicians to create a history of care leading to consultation with a
gynecologic oncologist. Although patient recall may be an efficient method to explore the context of the patient’s
concerns, the accuracy of recall and its potential impact on care are unknown. This study sought to explore the
consistency of patient recall compared with data found in health care records. Patients and Methods: This study
enrolled 105 eligible patients who were referred to a gynecologic oncologist for suspected ovarian cancer. Ninety-one
of these patients were interviewed regarding symptoms, health care events, and the dates leading to diagnosis. The
medical records of these patients from all previous providers were obtained and data were abstracted. The intraclass
correlation coefficient (intraclass correlation coefficient, ICC[3,1]) was used to examine correspondence between
recall and medical record data. Results: There was low correspondence between patient recall and the medical
record for time to diagnosis (ICC  0.12; 95% confidence interval [CI]  0.09 to 0.33; P  .12) and health care
events (0.15; 95% CI, 0.05 to 0.348; P  .008). Conclusions: There should be limited confidence in information
obtained from patient recall given the inconsistency between recall and actual dates and events.
Clinical Ovarian & Other Gynecologic Cancer, Vol. 5, No. 1, 17-23 © 2012 Elsevier Inc. All rights reserved.
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An estimated 22,280 women were diagnosed with ovarian cancer
in the United States in 2012, and 15,500 died of the disease.1 In a
ecent study by Bailey et al,2 30% of all patients referred to a gyne-
ologic oncologist for suspected ovarian cancer have nonsignificant
ndings at surgery. For the remaining 70%, prompt diagnosis and
urgical intervention is crucial for long-term survival.3
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http://dx.doi.org/10.1016/j.cogc.2012.04.001A potential barrier to a rapid diagnosis in the absence of screening
tests for ovarian cancer is that patients may undergo multiple clinic
visits and repeated assessments over an extended time to rule out
other conditions before referral to a gynecologic oncologist. An Aus-
tralian population-based telephone survey sought to examine the
pathways to diagnosis of ovarian cancer to explore this possibility.4
They found that women diagnosed with ovarian cancer experience
an average of less than 2 health care visits, during which only 10%
had their cancers diagnosed incidentally. The results from this study
suggest that women who present with symptoms are diagnosed rel-
atively quickly (80% self-reported that they were diagnosed within 3
months of initial presentation).4 This was slightly longer than the
verage one-month time to diagnosis recalled in an earlier Canadian
elf-report study.5 However both studies relied on patient recall of
ast events, and the reliability of recall in the setting of suspected
varian cancer is unknown.
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18 CThere is some debate regarding the reliability and accuracy of
patient recall in both the short term and long term for a variety of
conditions. Some studies have found patient recall of health care
events to be reliable (correlation coefficients ranging from 0.6-
1.0),6,7 whereas others have found that inaccurate recall of symptoms
and events is common, with up to 26% of patients who cannot
accurately recall previous health care events and procedures.8,9 We
are unaware of published research on the reliability or accuracy of
patient recall of symptoms or health care tests or events in the setting
of the diagnostic pathway to ovarian cancer. Therefore, there is a
need to explore the accuracy of patient recall of both health care
events (previous tests and visits) and time leading to diagnosis to
better understand the clinical implications of relying on patient
recall.
This study was designed to test the hypothesis that patient recall is
consistent with medical record data regarding health care events and
time to reach an accurate diagnosis. This evidence will enable us to
determine the confidence that we can have regarding the assump-
tions or conclusions that are made based on recall for clinical care in
this setting.
Patients and Methods
To be eligible for participation, participants were required to be 18
years of age, to not yet have undergone surgery but to have received
a referral for surgery, or to have undergone surgery within the past 12
months for a suspected ovarianmalignancy.Womenwith a diagnosis
of ovarian cancer or a definitive surgical procedure that was com-
pleted more than 12 months before enrollment were not eligible in
order to reduce recall bias and to be consistent with earlier studies of
symptoms and pathways to diagnosis.4,10,11
After providing written informed consent, eligible women partic-
ipated in a semistructured interview that was audio recorded to en-
sure data collection accuracy. The interview was designed for the
patient to first identify the situation or symptoms that prompted
seeking medical attention and to recall the experience from that time
to the time of surgery for the suspected ovarian malignancy. Vari-
ables collected during the interview process included the date of each
health care visit, physicians and other health care providers con-
sulted, tests, prescriptions, and referrals for each health care system
encounter/clinic visit from the time that a problem was first sus-
pected by the patient through the time of definitive pathologic diag-
nosis in order to be consistent with previous research.4,12 Only the
structured interview items were included in the current study and
analysis.Womenwere recruited from gynecologic oncology practices
in Indianapolis, Indiana and South Bend, Indiana from May 2009
through February 2010, when accrual goals were met.
After completion of study accrual, extensive medical record
searches were conducted to obtain all previous health care encounters
for each patient throughout the diagnostic period. Patient-recalled
health care events from the interview were used as the starting point.
Additional medical records for each patient were obtained for all
referrals and from notes suggesting additional tests or health care
visits during the diagnostic period that were not recalled by the pa-
tient. Data for each variable obtained in the interview and medical
record reports were entered and verified using Microsoft Access
(Microsoft, Corp, Redmond, WA). Health care visits unrelated to t
linical Ovarian & Other Gynecologic Cancer June 2012the path to diagnosis (eg, acute injuries, annual eye examinations,
routine hearing tests) were excluded from the analysis. The date of
diagnosis was defined as the date of definitive surgery with pathologic
diagnosis. In the case of biopsy with pathologic diagnosis without
definitive surgery, the biopsy date was used.
The theoretical framework for the diagnostic pathways is based on
Anderson’s model of total patient delay.13 This model is composed
f a series of patient and health care system factors, beginning with
he initial inference of illness from noted symptoms, leading to the
atient seeking medical attention and ultimately obtaining an accu-
ate diagnosis. For this study, the appraisal period is defined as begin-
ning at the first symptoms or health concern detected by the patient
or friends/family (whichever is earlier) and ending on the date of the
first medical encounter at which the problem was noted by the pa-
tient or provider. The diagnostic period is defined as the time from the
first medical encounter at which the health concern was noted by the
patient or provider through the time of definitive diagnosis. Defini-
tive diagnosis is defined as a pathologic or histologic diagnosis as
described above. The time-to-treatment period is defined as the time
from definitive diagnosis to time of chemotherapy (limited to pa-
tients diagnosed with cancer who are recommended to receive che-
motherapy). All study procedures were approved by the IndianaUni-
versity/Clarian Health and Northern Indiana Research Consortium
Institutional Review Boards.
The target accrual goal was 100 women to attempt to reach a
sample of 30 patients in each diagnostic category (ie, benign disease,
early-stage disease, and advanced-stage disease), which would allow
for 80% power to detect a correlation of 0.50 or greater in each
category and 80% power to detect low correlations (0.30) between
self-reports and the medical record data among women diagnosed
with ovarian cancer.14
All analyses were conducted using SPSS, version 15.0 (SPSS Inc,
Chicago, IL). Descriptive statistics were used to present participant
age, marital status, insurance status, race, and diagnosis of study
participants. For comparative analyses, racial categories were col-
lapsed into white/nonwhite categories because of the low recruit-
ment of Asian, Native American, and African American women and
women of other races. Reported symptoms, cancer vs. benign diag-
nosis, and cancer stage at diagnosis were compared for differences in
time periods using analysis of variance, with posttests adjusted for
multiple comparisons in the case of an overall significant result.
Mean differences in time periods by presence of symptoms, insur-
ance status, and cancer diagnosis vs. benign disease were conducted
using independent sample t tests, and correlations were performed to
xplore the relationship between age and time/events.
To assess the agreement of number and timing of health care
vents between patient recall and the medical record, the intraclass
orrelation coefficient (ICC)15 was used to evaluate the agreement
between raters (in this case between the self-report and the medical
record).16 Because of the nonrandomnature of these assessments, the
pearman-type ICC form (Model C) was used. The ICC Model C
ICC[3,1])17 was analyzed as a 2-waymixed effectsModel ICC using
PSS, version 15.0 (SPSS, Inc). If a significant correlation coefficient
as found, a comparison of means was performed to better interpret
he significant findings.18
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Lisa M. Hess et alFor consistency with previous research, which has reported num-
ber of months for the appraisal and diagnostic periods,4,10 patients
ho failed to recall time within 30 days of that found in the medical
ecord for the illness appraisal, diagnostic period, or time-to-treat-
ent period were considered to have inaccurate recall for those time
eriods. For the number of events, patients who failed to recall 3 or
ore health care visits were considered to have inaccurate recall,
hich is very conservative and equivalent to the total number of visits
xperienced by most patients from earlier research.4
Results
One hundred seven patients were enrolled in this study. One pa-
tient was excluded because more than 12 months had passed since
the diagnosis, and 2 additional patients changed their minds about
participating before scheduling a study interview. Of the 104 eligible
patients, 92 completed the study interview. Thirteen patients did not
complete the interview because they could not be reached by phone
or in person. One patient who was interviewed was excluded from
the analysis because all health care encounters occurred outside the
United States, resulting in a sample size of 91 patients who had
completed the interviews and had complete medical record data. A
summary of the characteristics of all eligible study participants and
those with complete data is shown in Table 1, and the initial health
characteristics and the most common symptoms (out of  20 re-
orted) at the time of illness appraisal is presented in Table 2. Disease
haracteristics at diagnosis are presented in Table 3.
The distributions of the difference between patient recall and
edical record data for the 3 time periods (illness appraisal, diagnos-
ic period, and time-to-treatment period) and for health care visits
re presented in histograms in Figure 1, with zero representing accu-
Table 1 Demographics of Study Participants
All Eligible
Participants
(n  104)
Complete Medical
and Interview
Data (n  91)
Age in Years, Mean
(Range) 56.4 (20–85) 57.53 (21–85)
Marital Status, n (%)
Married/partnered 59 (64.8%) 58 (65.2%)
Divorced/separated 11 (12.1%) 11 (12.4%)
Widowed 8 (8.8%) 7 (7.9%)
Never married 13 (14.3%) 13 (14.6%)
Not reported 13 2
Race/Ethnicity, n (%)
White, non-Hispanic 90 (91.8%) 84 (93.3%)
African American 5 (5.1%) 4 (4.4%)
Native American 1 (1.0%) 1 (1.1%)
Asian 2 (2.0%) 1 (1.1%)
Not reported 6 1
Health Insurance,
Yes — 81 (89.0%)acy of recall, negative differences representing patient underestima-tion of time or events, and positive differences representing patient
overestimation of time or events.
Illness Appraisal Period
Four patients (4.4%) identified becoming aware of potential
illness after first seeking medical care, so the illness appraisal pe-
riod was set to zero according to patient recall. However accord-
ing to the medical record, 27 (29.7%) patients had seen a health
care provider related to these concerns before the time they re-
ported as first suspecting illness. According to patient recall, the
illness appraisal period was an average of 72 days (range 0-1096
days). There was a significant positive relationship between age
and the illness appraisal period (P  .02) according to patient
ecall. Patient recall of appraisal could not be verified in the med-
cal record, since this event occurred independently of any med-
cal care obtained or received.
Diagnostic Period
Three patients could not recall the date of diagnosis and were
Table 2 Most Frequent Patient-Reported Symptoms at Time
of Illness Appraisal
Symptom All Patients(n  91)
Cancer Diagnosis
(n  63)
Did Not
Experience
Symptoms
14 (15.4%) 6 (9.5%)
Abdominal Pain 24 (26.4%) 20 (31.7%)
Abdominal
Bloating 28 (30.8%) 22 (34.9%)
Back Pain 15 (16.5%) 7 (11.1%)
Pelvic Pain 10 (11.0%) 7 (11.1%)
Frequent
Urination 7 (7.7%) 5 (7.9%)
Average Number
of Symptoms
(Range)
1.48 (0-4) 1.59 (0-4)
Table 3 Final Diagnosis (n  91)
Diagnosis Patient Recall Medical Record
Benign Disease 27 (29.7%) 24 (26.4%)
Cancer 61 (67.0%) 63 (69.2%)
Stage 1 8 (13.1%) 9 (14.3%)
Stage 2 10 (16.4%) 11 (17.5%)
Stage 3 24 (39.3%) 30 (47.6%)
Stage 4 4 (6.6%) 4 (6.3%)
Unknown/not
reported 5 (8.2%) 3 (4.8%)
Not staged 10 (16.3%) 6 (9.5%)
Tumor of Low
Malignant
Potential
3 (3.3%) 4 (4.4%)excluded from the comparison and correlation analyses. Overall, pa-
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20 Ctients reported an average of 143.6 days (range 0-3479 days) for the
diagnostic period. In the medical record review, the diagnostic pe-
riod was found to be an average of 71.7 days (range 0-697 days).
There was no difference in the patient-recalled and medical record
diagnostic time periods according to insurance status, symptomatic
or asymptomatic disease, cancer vs. benign disease, race, marital sta-
Figure 1 Distribution of Differences Between Patient-Recalled
and Medical Record Time Periods. (A) Diagnostic
Time Period. (B) Time-To-Treatment Time Period.
(C) Health Care Visits (Excluding Testing-Only
Visits)
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linical Ovarian & Other Gynecologic Cancer June 2012There was a mean difference of 71.8 days between patient
estimation of the time to diagnosis compared with that found in
the medical record (range of an underestimation of 181 days to an
overestimation of 3430 days). The ICC between the patient-re-
called and medical record diagnostic time period was 0.122 (95%
confidence interval [CI],0.085 to 0.329; P .12), demonstrat-
ing no agreement. More than a quarter (27.3%) of patients could
not accurately recall the diagnostic period within 30 days.
Time-to-Treatment Period
Of the 63 patients who were diagnosed with cancer in this study,
58 planned to have or had received chemotherapeutic treatment. Six
patients had not yet decided on the start date of chemotherapy at the
time of the interview or did not know the date of diagnosis and were
excluded from the comparative analyses because of the inability to
calculate a time-to-treatment period for patient recall. The patient-
recalled time-to-treatment period was an average of 34.6 days (range
0-162 days); in the medical record this period was 33.2 days (range
0-132 days). There was very high consistency between the patient-
recalled and medical record time-to-treatment periods, with an ICC
of 0.808 (95% CI, 0.687-0.886; P  .001), demonstrating high
agreement. There were no significant differences between these 2
data collection methods, with a mean difference of 3.8 days (range of
an underestimation of 48 days to an overestimation of 64 days). The
vast majority of patients were able to accurately recall the time-to-
treatment period, with only 3 patients (5.9%) unable to accurately
recall this period within 30 days.
There was a significant difference according to patient recall
based on insurance status, with uninsured patients reporting an
average of 56.2 days from diagnosis to treatment vs. insured pa-
tients reporting an average of 31.8 days (P  .03); however there
was no significant difference according to the medical record data.
There were no significant differences in time to treatment by race
or marital status. There was no difference in time to treatment by
age according to patient recall; however in the medical record
there was a significant relationship between age and time to treat-
ment, with older patients receiving treatment more rapidly than
younger patients (P  .02).
Number of Health Care Visits
Patients recalled having an average of 3.4 health care visits
(range, 1-8), and according to the medical records patients had an
average of 7.1 health care visits (range, 2-27) during the diagnos-
tic period (Table 4). The ICC between the patient-recalled and
medical record events was 0.149 (95% CI, 0.05 to 0.348; P 
.008), demonstrating low agreement. Patient recall reported sig-
nificantly fewer events than did the medical records (P  .001).
On average, patients underestimated the number of health care
visits by 3.7 (range, underestimation of 20 events to overestima-
tion of 4 events). Fifty-two participants (57.1%) were inaccurate
by 3 or more visits when all visits, including tests and assessments,
were included.
When health care visits involving testing and assessments only (eg,
no health care provider was seen), there remained a low agreement
between patient recall and the medical record (ICC  0.268; 95%
CI, 0.002-0.487; P  .001). There was an average of 3.1 visits
(range, 1-8) according to patient recall and 5.1 medical record events
gLisa M. Hess et al(range, 2-19) when all testing visits were excluded. There were a
significantly lower number of recalled events than medical record
events (P  .001), with an average underestimation of 2 medical
visits (range, underestimation of 14 events to an overestimation of 4
visits). Twenty-eight patients (30.8%) could not recall 3 or more
health care visits when all testing and assessment visits were excluded
from the computation.
When comparing the number of events by patient characteristics,
insured patients (P  .05) and patients with symptoms (P  .01)
reported significantly more health care events (including testing)
than did uninsured patients or patients without symptoms, respec-
tively; however this was not different according to the medical re-
cords or when tests were excluded in the patient self-report. There
was no difference in number of health care visits between patients
who were later diagnosed with cancer and those with benign disease
or by marital status, race, or age.
Providers and Tests
According to patient recall, there were a total of 313 health care
visits during the diagnostic period, including 28 visits for testing
only. In the medical record, there were 648 visits, including 179
for testing only (Table 5). The most common practitioners seen
for the initial presentation, according to patient recall, were pri-
mary care physicians (n  50 [54.9%]), emergency room or ur-
ent care (n  18 [18.8%]), or gynecologists (n  8 [8.8%]).
Similarly, in the medical record it was found that 46 women
(50.5%) first presented to a primary care physician, 24 (26.4%)
presented to the emergency room or an urgent care facility, and 8
(8.8%) presented to a gynecologist. Of the 63 patients who were
diagnosed with cancer, 47 (74.6%) reported seeing a gynecologic
Table 4 Visits to Health Care Professionals During the Diagnos
Number of
Visits
Patient Recall
All Visits Excluding VisTests/Assess
1 1 (1.1%) 2 (2.2%)
2 28 (30.8%) 34 (37.4%
3 2 (28.6%) 30 (33%)
4 20 (22%) 14 (15.4%
5 7 (7.7%) 4 (4.4%)
6 4 (4.4%) 3 (3.3%)
7 1 (1.1%) 1 (1.1%)
8 4 (4.4%) 3 (3.3%)
9 0 0
10 0 0
11 0 0
12 0 0
13 0 0
14 0 0
15 0 0
Mean (Range) 3.4 (1-8) 3.1 (1-8)oncologist before diagnosis. According to the medical record, 49(77.8%) patients who were diagnosed with cancer saw a gyneco-
logic oncologist before pathologic diagnosis. Participants were
least likely to recall visits for testing only or visits to a gastroen-
terologist and were most likely to recall visits to a gynecologist,
gynecologic oncologist, or urologist. Patients who saw a gyneco-
logic oncologist during the diagnostic period recalled a signifi-
cantly shorter time to diagnosis (P .001); however there was no
difference in time to diagnosis according to the medical record.
There was no significant difference in the diagnostic period de-
pending on where the patient initially presented for care. How-
ever when outliers were removed (patients with longer than a
3-year diagnostic period), those first presenting to primary care
physicians, gynecologists, or the emergency room reported a sig-
nificantly shorter time to diagnosis (P  .01). There was no
difference in time by provider at initial presentation according to
the medical record even when the outliers were removed. There
was also no significant difference in the number of health care
visits during the diagnostic period, depending on the provider
seen at initial presentation, if the patient was currently receiving
chemotherapy, or based on time between diagnosis and study
interview.
Factors Related to Recall
There was no difference in accuracy of the recalled periods
(diagnostic period or time to treatment) according to insurance
status, cancer diagnosis, initial symptoms, race, or marital status.
However, patients who inaccurately recalled the diagnostic period
were more likely to be older. Patients with accurate recall were an
average age of 55 years and those with inaccurate recall of the
diagnostic time period were an average age of 63.3 years (P 
eriod, Number of Patients (%)
Medical Record Data
r
s All Visits
Excluding Visits for
Tests/Assessments
0 0
4 (8.8%) 6 (6.6%)
8 (12.1%) 18 (19.8%)
11 (12.1%) 24 (2.4%)
8 (8.8%) 15 (16.5%)
12 (13.2%) 11 (12.1%)
16 (17.6%) 6 (6.6%)
13 (14.3%) 5 (5.5%)
5 (5.5%) 1 (1.1%)
5 (5.5%) 1 (1.1%)
1 (1.1%) 0
1 (1.1%) 1 (1.1%)
1 (1.1%) 0
3 (3.3%) 0
3 (3.3%) 3 (3.3%)
7.1 (2-27) 5.1 (2-19)tic P
its fo
ment
)
).007). Age was not associated with accuracy of recall for the illness
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22 Cappraisal or for the time-to-treatment periods. Patients with a
longer appraisal period (according to the medical record) were
more likely to inaccurately report that period, but there was no
difference in either the diagnostic period or time-to-treatment
period between those who reported inaccurate time periods and
those who reported them accurately.
There was no difference in accuracy of the recalled periods
(diagnostic or time to treatment) according to insurance status,
cancer diagnosis, initial symptoms, race, marital status, age, cur-
rent chemotherapy exposure, or time from diagnosis to study
interview. Accuracy of recall of visits was significantly related to
the number of visits that occurred during the diagnostic period.
Patients who accurately recalled their health care visits (did not
miss more than 2 visits), had an average of 4.6 visits, whereas
patients who failed to recall 3 or more events had an average of 9
health care visits during the diagnostic period (P  .03). This
relationship was similar when the visits for tests only were re-
Table 5 Health Care Use During the Diagnostic Period (n  91
Provider Type
Patient Re
Number (%)
of Patients
Primary Care 57 (62.6%)
Emergency/Urgent Care 24 (26.4%)
Gynecologist 30 (33.0%)
Gynecologic Oncologist 74 (81.3%)
Medical Oncologist 6 (6.6%)
Gastroenterologist 12 (13.2%)
Urologist 3 (3.3%)
Other specialist 15 (16.5%)
Health Care Visit for Testing Only 23 (25.3%)
Could Not Recall Who was Seen 8 (8.8%)
Tests
Patient Re
Number (%)
of Patients
Blood Tests 54 (59.3%)
Radiography 21 (23.1%)
Computed Tomography 57 (62.6%)
Cardiac Testing 11 (12.1%)
Ultrasonography 48 (52.7%)
Urinalysis 4 (4.4%)
Papanicolaou Test 7 (7.7%)
Colonoscopy 11 (12.1%)
Magnetic Resonance Imaging 12 (13.2%)
Biopsy 5 (5.5%)
Paracentesis 7 (7.7%)
Mammography 5 (5.5%)
Other tests 13 (14.3%)moved from the analysis, with an average of 3.9 visits for patients m
linical Ovarian & Other Gynecologic Cancer June 2012with accurate recall vs. 7.9 events for those who could not recall 3
or more events (P  .001).
Discussion
Patients referred to a gynecologic oncologist for suspected
ovarian cancer did not accurately recall their health care experi-
ence leading to referral and diagnosis. Although patients could
recall time periods (generally within 30 days), they were not as
likely to recall all the health care visits that occurred during that
period. Although these study participants were recruited from
Indiana, the patients (demographic and clinical variables) and
their self-reported data (time and events) in this study are very
similar to those in the Goff symptom10 and Australian path-
ay4,19 studies. For example, patients in this study reported an average
of 3.4 visits to reach diagnosis, similar to the 2.6 visits reported in the
Australian study.4 However in the medical record, there was an average
f 7.2 visits, and it was found that 58% of patients failed to recall 3 or
Medical Record
otal Visits
n  313)
Number (%)
of Patients
Total Visits
(n  648)
81 55 (60.4%) 117
27 31 (34.1%) 36
42 33 (36.3%) 62
83 76 (83.5%) 163
6 4 (4.4%) 5
14 17 (18.7%) 26
3 3 (3.3%) 4
20 32 (35.2%) 56
28 75 (82.4%) 179
8 — —
Medical Record
otal Tests
n  329)
Number (%)
of Patients
Total Tests
(n  761)
80 88 (96.7%) 240
25 61 (67.0%) 79
75 72 (79.1%) 91
12 54 (59.3%) 72
70 62 (68.1%) 71
5 52 (57.1%) 67
8 30 (33.0%) 30
13 12 (13.2%) 12
12 9 (9.9%) 10
5 14 (15.4%) 15
8 13 (14.3%) 13
5 9 (9.9%) 10
15 35 (38.5%) 51)
call
T
(
call
T
(ore visits. Patients reported an average of 4 months to reach diagnosis
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Lisa M. Hess et alin this study, similar to the 4.4 months reported in the Goff symptoms
study.4,19 However, when compared with the medical records it was
ound that patients underreported the time to diagnosis on average by
ore than 1 month. This suggests that the pathway to diagnosis of
varian cancer uses many more health care system resources that
ad previously been reported.
It is unlikely that the medical record data are affected by the ret-
ospective nature of data collection, as the number and type of
vents, providers, and tests should not be affected. It would be prac-
ically impossible to conduct a similar study prospectively because
he sample would necessarily require many thousands of healthy
omen to find up to 100 women who might possibly suspect a
alignancy in the future. However because of the retrospective na-
ure of data collection, there is the possibility of missed events or tests
n the medical record, which would only serve to increase the dis-
repancy between recall and actual events. There is also the possibil-
ty of better recall in this study because of the detailed survey proce-
ures used to elicit details of each test, visit, and physician seen
hroughout the diagnostic period. In clinical practice, it is possible
hat less detailed methods are used to create a recent medical history,
nd this study may underestimate recall in a natural setting.
The study population was limited to patients in Indiana and may
ot be generalizable to the larger population with ovarian cancer.
owever both private practices and an academic site recruited pa-
ients to enhance the representativeness of study participants. Addi-
ionally, the demographic and clinical characteristics and the self-
eported data are very similar to the data collected in other
opulation-based and recall trials (including mean age, disease stage,
nd percent reporting symptoms),4,10 suggesting that this study pop-
ulation is comparable to those in previous work.
Medical record review is complex and challenging, particularly in
a fragmented health care system. Time and resources are needed to
identify, obtain, and record health care system events, resources, and
practitioners involved in the diagnostic pathway. The use of a claims
database is a potential solution but may affect the outcomes because
of the specific guidelines and recommendations for tests and referrals
within that particular insurance system.However, the results of stud-
ies that rely on claims data may not be generalizable to all payers.
Conclusion
Patients with suspected ovarian cancer did not accurately recall
health care events or time leading to referral to a gynecologic oncol-
ogist and diagnosis. In this study, 60% of patients were inaccurate in
their recall by more than 3 health care events, and approximately
10% were inaccurate by more than 7 events. More than 27% of
patients did not recall the period in which the events occurred within
30 days, and approximately 15% could not recall the time within 70
days. Only 5.5%were highly accurate in the correct recall of number
of health care events, and 40% were highly accurate regarding time
(within 1 week of what was found in the medical record).
Patients are most likely to fail to recall tests that have been per-
formed. It will always be necessary for some research to be conducted
that relies on patient self-reporting of time or events. Based on the
findings of this study, research using patient recall data should takeinto account the uncertainty and error in self-reported data
and perhaps adjust conclusions based on the potential range of inac-
curacy. Conclusions from self-reports should not assume that there is
no uncertainty in the results.
Clinical Practice Points
● If clinical decisions are to be made based on previous health care
events, tests, or time to referral, the discrepancy between patient
recall and medical record data cannot be ignored.
● Medical record review is recommended for research, particularly if
recommendations for care will depend on results obtained from
patient-recalled time or event data.
● Clinicians should recognize the inaccuracy of patient recall of
health care events and time in the setting of referral to a gyneco-
logic oncologist for suspected ovarian cancer.
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